Trial record 1 of 1 for:
NCT01387035
Early Diagnosis of Pulmonary Hypertension in Patients With Inflammatory Rheumatic Connective Tissue Diseases
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01387035 |
|
Recruitment Status :
Recruiting
First Posted : July 4, 2011
Last Update Posted : July 14, 2022
|
Sponsor:
Heidelberg University
Information provided by (Responsible Party):
Prof. Dr. med. Ekkehard Gruenig, Heidelberg University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Brief Summary:
The purposes of this study are (I), to evaluate various screening methods for their ability to predict and to confirm Pulmonary Hypertension (PH) in scleroderma patients, and (II) to evaluate the incidence of PH (i.e. the number of new cases per year) in scleroderma patients.
| Condition or disease |
|---|
| Connective Tissue Disease Pulmonary Hypertension |
| Study Type : | Observational |
| Estimated Enrollment : | 50 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Early Diagnosis of Pulmonary Hypertension in Patients With Inflammatory Rheumatic Connective Tissue Diseases |
| Study Start Date : | January 2010 |
| Estimated Primary Completion Date : | December 2025 |
| Estimated Study Completion Date : | December 2025 |
Resource links provided by the National Library of Medicine
MedlinePlus Genetics related topics:
Hypertension
Primary Outcome Measures :
- Evaluation of various screening methods for their ability to predict and to confirm PH in scleroderma patients [ Time Frame: 3 years ]Correlate Spiroergometric, lung functional Magnetic Resonance Imaging (MRI) and echocardiographic parameters with invasive hemodynamic findings collected by right heart catheterization: which other non-invasive parameters can be found to detect pulmonary hypertension? Can pulmonary hypertension be detected at rest in the echocardiography? In which patients can only stress-Doppler echocardiography confirm manifest or latent pulmonary hypertension? Is stress-Doppler echocardiography a suitable for early detection of pulmonary hypertension in patients with collagen vascular disease?
Secondary Outcome Measures :
- Subdivision of patients with connective tissue disease in different degrees of severity [ Time Frame: 3 years ]Can spiroergometric findings help to subdivide patients with connective tissue diseases into groups according to degrees of severity, and differ the patients based on spiroergometric findings? To what extent is this distinction comparable with the classifications for the "functional classes" (application for PH according to the New York Heart Association (NYHA) classification)
Information from the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Study Population
Included are all patients who fulfill the current definition of a collagen vascular disease according to the actual guidelines of the American College of Rheumatology (ACR) and who are 18 years or older.
Criteria
Inclusion Criteria:
- consent form
- men and women> 18 years
- fulfill the current definition of a collagen vascular disease according to the actual guidelines of the American College of Rheumatology (ACR)
Exclusion Criteria:
- all contraindications for exercise testing
- significant restriction of the left ventricle, unstable coronary artery disease and myocardial infarction in the last 6 months
- patients with other lung diseases (as the pulmonary infestations as part of systemic disease) or related musculoskeletal disorders influencing baseline exercise capacity
- pregnancy
Information from the National Library of Medicine
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01387035
Contacts
| Contact: Ekkehard Grünig, MD, Prof. | +49 6221 396 8053 | ekkehard.gruenig@med.uni-heidelberg.de |
Locations
| Germany | |
| Center for pulmonary Hypertension, Thoraxclinic Heidelberg | Recruiting |
| Heidelberg, Germany, 69126 | |
| Contact: Christian Nagel, MD +49 6221 396 8063 christian.nagel@thoraxklinik-heidelberg.de | |
| Contact: Ekkehard Grünig, Professor +49 6221 396 8053 ekkehard.gruenig@thoraxklinik-heidelberg.de | |
| Principal Investigator: Christian Nagel, MD | |
Sponsors and Collaborators
Heidelberg University
Investigators
| Study Director: | Christian Nagel, MD | Center for pulmonary hypertension, Thoraxclinic Heidelberg | |
| Study Director: | Ekkehard Grünig, Professor | Center for pulmonary hypertension, Thoraxclinic Heidelberg |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Prof. Dr. med. Ekkehard Gruenig, Prof. Dr. med. Ekkehard Grünig, Heidelberg University |
| ClinicalTrials.gov Identifier: | NCT01387035 |
| Other Study ID Numbers: |
S-360/2009 |
| First Posted: | July 4, 2011 Key Record Dates |
| Last Update Posted: | July 14, 2022 |
| Last Verified: | July 2022 |
Additional relevant MeSH terms:
|
Hypertension, Pulmonary Hypertension Connective Tissue Diseases Vascular Diseases |
Cardiovascular Diseases Lung Diseases Respiratory Tract Diseases |